Premium
Serum levels of insulin‐like growth factor (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion
Author(s) -
HALL K.,
JOHANSSON B. L.,
PÓVOA G.,
THALME B.
Publication year - 1989
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/j.1365-2796.1989.tb00078.x
Subject(s) - medicine , endocrinology , insulin , morning , diabetes mellitus , insulin like growth factor binding protein , insulin like growth factor , growth factor , receptor
. IGF‐I and IGF‐II as well as the low molecular type of IGF binding protein (IGFPB) were determined in serum from 11 adolescents with insulin‐dependent diabetes mellitus (IDDM) during a cross‐over study with conventional and continuous subcutaneous insulin infusion (CIT and CSII) therapy. At the onset of the study the mean IGF‐I level, 127 ± 15 ng ml −1 , was significantly decreased ( P < 0.001) in comparison with age‐matched controls, whereas the mean IGF‐II level, 1024 ± 48 ng ml −1 . was increased. A significant correlation ( r = 0.70, P < 0.05) was found between IGF‐II and HbA 1 c levels. The mean morning level of IGFBP, 75 ± 17 ng ml −1 , at the onset of the study, was increased threefold above that in age‐matched controls ( P < 0.01). There was a significant correlation between IGFBP and blood glucose values ( r = 0.66, P < 0.05). During CSII therapy a significant decrease ( P < 0.05) of the IGFBP levels was seen in subjects with a decrease in glucose levels, whereas no change was observed in IGF levels. The findings of elevated IGF‐II and IGFBP levels and correlations between IGFBP and blood glucose concentration as well as IGF‐II and HbA 1 c levels in adolescents with IDDM indicate that both IGF‐II and IGFBP reflect a deranged metabolism caused by inadequate insulin administration.